Al Kaissi Syndrome; Alkas
Al Kaissi syndrome is an autosomal recessive developmental disorder characterized by growth retardation, spine malformation, particularly of the cervical spine, dysmorphic facial features, and delayed psychomotor development with moderate to severe intellectual disability (summary by Windpassinger et al., 2017).
Genes related to Al Kaissi Syndrome; Alkas
Clinical FeaturesTop most frequent phenotypes and symptoms related to Al Kaissi Syndrome; Alkas
- Intellectual disability
- Global developmental delay
- Short stature
- Generalized hypotonia
- Growth delay
- Abnormal facial shape
- Low-set ears
And another 37 symptoms. If you need more information about this disease we can help you.
Incidence and onset information— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
— No data available about the known clinical features onset.
Al Kaissi Syndrome; Alkas Is also known as growth retardation, spine malformation, dysmorphic facies, and developmental delay.
Researches and researchersCurrently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.
Al Kaissi Syndrome; Alkas Recommended genes panels
|Panel Name, Specifity and genes Tested/covered|
By Fulgent Genetics Fulgent Genetics (United States).
Tempus xO assay.
By Tempus Labs, Inc. (United States).
BCL6, RHEB, RIPK1, RIPK2, RIPK3, RIT1, BCL7A, BCL9, BCR, ROBO2, ROCK1, ROCK2, ROR1, ROR2, ROS1, RPA1, BDNF, RPL5, RPN1, RPS6KB1 , (...)
View the complete list with 1627 more genes
You can get up to -6 more panels with our dedicated toolLearn more
Sources and references
You can check the following sources for additional information.OMIM Rare Disease Search Engine
If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME; SIDDT MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9 GALACTOSE EPIMERASE DEFICIENCY HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1